Elizabethkingia Infection - Complete Answer (30 Marks)

1. Introduction and Historical Background

• E. meningoseptica - most historically described; classic neonatal pathogen
• E. anophelis - now the most frequently isolated species in clinical settings (~59% of isolates)
• E. miricola
• E. bruuniana, E. occulta, E. ursingii - less common

2. Microbiology / Morphology

• Grows well on blood agar and MacConkey agar
• Produces a characteristic yellow pigment (flexirubin), which distinguishes it from many other gram-negative organisms
• Identification: MALDI-TOF mass spectrometry is used in modern labs; 16S rRNA gene sequencing is the gold standard for species-level differentiation
• MALDI-TOF can identify E. meningoseptica and E. anophelis but cannot reliably differentiate all species

3. Epidemiology

Reservoir and Habitat

• Found in soil, water, plants, and hospital environments (environmental organism)
• Commonly isolated from hospital water systems, sinks, taps, humidifiers, respiratory therapy equipment, intravenous fluids, disinfectants, and aerosolized antibiotics
• Has been isolated from the gut of Anopheles gambiae mosquitoes (E. anophelis)

At-Risk Populations

1. Preterm neonates and low-birth-weight infants - most vulnerable (neonatal meningitis outbreaks)
2. Immunocompromised patients - malignancy, diabetes, corticosteroid therapy, leukemia, aplastic anemia, asplenia, congenital immunodeficiency
3. ICU patients - mechanical ventilation, indwelling central venous catheters, Foley catheters, endotracheal tubes
4. Patients on broad-spectrum antibiotics - creates selection pressure
5. Elderly (>65 years) - E. anophelis in particular
6. Patients with tuberculosis, chronic renal failure, cirrhosis, cystic fibrosis

Mode of Transmission

• Nosocomial (healthcare-associated) - the predominant mode
• Outbreaks via contaminated IV fluids, disinfectants, respiratory equipment, sink drains
• Person-to-person transmission via healthcare workers
• Outbreaks persist until extensive environmental cleaning is performed

4. Pathogenesis

• The organism is of low virulence in immunocompetent hosts
• Bacterial load, immune status, and selective antibiotic pressure determine invasive disease
• Produces metallo-beta-lactamases (MBLs) encoded by blaB, blaGOB, and blaCME genes - conferring intrinsic resistance
• Biofilm formation on medical devices facilitates nosocomial infection
• In neonates: immature immune system, lack of maternal antibody, and blood-brain barrier immaturity allow meningitic spread
• In immunocompromised adults: invasion occurs via respiratory tract or intravascular devices

5. Clinical Features / Manifestations

5a. Neonatal Disease (Classic Presentation)

• Neonatal meningitis - the hallmark; occurs in outbreaks in NICUs
• Neonatal septicemia - fever, temperature instability, apnea, cyanosis, lethargy, irritability, poor feeding, jaundice
• Mortality rate in neonates: ~23.1% (though recovery rate ~76.9% with treatment)
• Associated with premature birth, NICU stay, invasive devices

5b. Infections in Immunocompromised Adults / ICU Patients

• Pneumonia (most common in adults, especially ventilator-associated pneumonia/VAP): mortality rate up to 60%
• Bacteremia / Bloodstream infection: often from intravascular catheters
• Meningitis: also in immunocompromised adults (not just neonates)
• Sepsis: fever, hypotension, respiratory distress, multi-organ dysfunction
• Endocarditis: rare but reported
• Urinary tract infection: usually catheter-associated
• Soft tissue infections
• Eye infections (conjunctivitis, endophthalmitis)
• Peritonitis: especially with peritoneal dialysis catheters
• Infective endocarditis

5c. Community-Acquired (rare)

• Seen mainly in geriatric patients
• Most common presentation: pneumonia
• Occurs infrequently in older immunocompetent patients

Species-Specific Mortality

• E. anophelis has the highest reported mortality rate among Elizabethkingia species
• Mortality in adults with comorbidities is significantly higher than in children
• In adults aged 18-60 and >60 years: higher mortality than in children

6. Diagnosis

Microbiological Diagnosis

1. Blood cultures - for bacteremia/sepsis
2. CSF analysis and culture - for meningitis (shows gram-negative bacilli, elevated protein, low glucose, pleocytosis)
3. Sputum / BAL culture - for pneumonia
4. Urine culture - for UTI
5. Colonial morphology - yellow-pigmented colonies on blood agar

Identification Methods

• MALDI-TOF MS - rapid identification in modern microbiology labs
• 16S rRNA gene sequencing - gold standard for species-level identification
• Whole genome sequencing (WGS) - definitive speciation
• Pulsed-Field Gel Electrophoresis (PFGE) - used for outbreak investigation (epidemiological typing)
• CDC laboratory is the reference center in the US for strain-level differentiation

Susceptibility Testing

• Clinical Laboratory Standards Institute (CLSI) developed interpretive breakpoints for E. meningoseptica MICs in 2013
• Minimum Inhibitory Concentration (MIC) testing is mandatory to guide therapy
• Results are unusual - susceptibility patterns are "reverse" of typical gram-negatives

7. Antimicrobial Resistance - Key Feature

Intrinsic Resistance (Unusual Pattern)

Usually Susceptible ("Reverse" Pattern - typical of gram-POSITIVES)

This unusual susceptibility pattern (susceptible to antibiotics typically used for gram-positives - vancomycin, rifampicin) is a hallmark of Elizabethkingia and is a classic exam point.

Resistance Mechanisms

• Metallo-beta-lactamases (MBLs): blaB, blaGOB (GOB-type), blaCME - present in all clinical isolates
• Extended-spectrum beta-lactamases (ESBLs): increasingly reported
• Multidrug-resistant (MDR) isolates are increasing globally

8. Treatment

General Principles

• No optimal/standardized regimen exists
• Treatment must be guided by in vitro susceptibility testing (MIC results)
• Empiric therapy considers the unusual susceptibility pattern

Treatment Options (per Harrison's 22e)

• Fluoroquinolones (ciprofloxacin, levofloxacin)
• Minocycline - drug of choice for fully MDR isolates
• Trimethoprim-sulfamethoxazole
• Piperacillin/tazobactam

• Minocycline alone or in combination
• Vancomycin (for meningitis - unusual use against a gram-negative)
• Combination therapy may be required for successful treatment

Special Considerations

• Meningitis: Vancomycin has been used (intrathecal/intraventricular) given its unusual susceptibility; rifampicin is an adjunct
• Carbapenem-sparing strategy is already built-in (organism is resistant)
• Remove any indwelling devices (source control) when possible
• Outbreaks require extensive environmental decontamination of hospital surfaces and equipment

9. Prevention and Infection Control

• Environmental surveillance - regular culture of hospital water, sinks, respiratory equipment
• Hand hygiene - essential for healthcare workers
• Aseptic technique for IV line insertion and maintenance
• Contact precautions in outbreak settings
• Decontamination of hospital equipment - humidifiers, ventilators, endoscopes
• Antibiotic stewardship - avoiding unnecessary broad-spectrum antibiotics
• All isolates should be reported to state laboratories and the CDC (in the US) for surveillance and outbreak investigation

10. Prognosis

• Overall prognosis depends on: species, age group, immune status, comorbidities, and timeliness of targeted therapy
• Neonates: Recovery rate ~100% (with appropriate therapy); better than adults
• Infants: ~85.7% recovery
• Adults with comorbidities: Higher mortality, especially with E. anophelis bacteremia (up to 18.2% in some US series)
• VAP (ventilator-associated pneumonia): Mortality up to 60%
• Precise species identification and targeted antibiotics are key to optimizing outcomes
• Lack of targeted therapy is a key factor in treatment failure

Summary Table for Quick Revision

• Harrison's Principles of Internal Medicine, 22nd Edition (2025), Chapter 163 - Elizabethkingia/Chryseobacterium Species section
• Red Book 2021 - Report of the Committee on Infectious Diseases - Neonatal Gram-Negative Septicemia section
• Jiang B et al. (2025). A systematic review of reported symptomatic Elizabethkingia infection cases in children and adults. Acta Tropica [PMID: 39909316]
• Tan JWY et al. (2026). Elizabethkingia Species as an Emerging Pathogen: A Comprehensive Review. Pathogens [PMID: 41901731]